Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
Syringe agitation may contribute to silicone oil dispersion after pegcetacoplan injection
A research letter published in JAMA Ophthalmology described the case of a patient with geographic atrophy who reported multiple small floaters after intravitreal injection of pegcetacoplan.
Apellis receives J-code for Syfovre
CMS assigned a permanent, product-specific J-code for Syfovre for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Apellis Pharmaceuticals.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Expert explains sialic acid-coated nanoparticle for geographic atrophy
SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Tarek S. Hassan, MD, discusses a novel treatment paradigm under investigation for geographic atrophy and dry age-related macular degeneration.
Optometric task force releases standards for diabetic retinopathy management
LKC Technologies has released Modern Fundamentals of Diabetic Retinopathy Management in Optometry, a new consensus document developed by a task force of medical optometry educators to guide patient care.
AOA: Eye safety a priority for upcoming annular solar eclipse
In preparation for the annular solar eclipse on Saturday, Oct. 14, the American Optometric Association is emphasizing the importance of eye safety to protect eye health and vision during the celestial event.
Izervay slows geographic atrophy growth at 24 months
Izervay met its primary objective of slowing geographic atrophy growth compared with sham at 24 months in the phase 3 GATHER2 clinical trial, according to a press release from Astellas Pharma.
Ophthalmic community mourns loss of Kirk H. Packo
Kirk H. Packo, MD, professor and chairman emeritus of the department of ophthalmology at Rush University Medical Center in Chicago, died Sept. 1, according to an announcement from Illinois Retina Associates.
EyePoint reports positive interim safety data for diabetic retinopathy, wet AMD treatment
EyePoint Pharmaceuticals has announced positive interim masked safety data for its investigational EYP-1901 for treatment of moderate to severe nonproliferative diabetic retinopathy and wet age-related macular degeneration.
Q&A: Prevent Blindness launches Gr8 Eye Movement with award-winning actress Debbie Allen
Prevent Blindness has teamed up with Regeneron and award-winning actress, dancer and director Debbie Allen to launch the Gr8 Eye Movement, a new campaign that aims to prioritize eye health and heighten awareness of serious retinal diseases.
VIDEO: FARETINA-DME study continues to shed light on faricimab treatment in DME
SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Durga Borkar, MD, MMCi, discusses the FARETINA-DME study investigating real-world outcomes of faricimab treatment in diabetic macular edema.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read